• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yokota Chisato  横田 千里

ORCIDConnect your ORCID iD *help
Researcher Number 10771909
Other IDs
Affiliation (Current) 2025: 大阪大学, 大学院医学系研究科, 特任助教(常勤)
Affiliation (based on the past Project Information) *help 2019 – 2021: 大阪大学, 医学系研究科, 招へい教員
Review Section/Research Field
Principal Investigator
Basic Section 56010:Neurosurgery-related
Keywords
Principal Investigator
ワクチン / グリオーマ / 脳腫瘍 / がん免疫 / 免疫療法 / がんワクチン / 複合免疫療法 / PD-1 / 免疫チェックポイント / 膠芽腫 / WT1 / がんペプチドワクチン
  • Research Projects

    (1 results)
  • Research Products

    (4 results)
  •  The study of combination immunotherapy of Wilms' Tumor 1 (WT1) peptide vaccine in pediatric brain tumorPrincipal Investigator

    • Principal Investigator
      Yokota Chisato
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56010:Neurosurgery-related
    • Research Institution
      Osaka University

All 2021 2019

All Journal Article Presentation

  • [Journal Article] Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy2021

    • Author(s)
      Yokota Chisato、Kagawa Naoki、Takano Koji、Chiba Yasuyoshi、Kinoshita Manabu、Kijima Noriyuki、Oji Yusuke、Oka Yoshihiro、Sugiyama Haruo、Tsuboi Akihiro、Izumoto Shuichi、Kishima Haruhiko、Hashimoto Naoya
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: 71 Issue: 1 Pages: 189-201

    • DOI

      10.1007/s00262-021-02954-z

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18390, KAKENHI-PROJECT-19K08345, KAKENHI-PROJECT-19K09457, KAKENHI-PROJECT-19K09526, KAKENHI-PROJECT-19K18426, KAKENHI-PROJECT-22K09283
  • [Journal Article] Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies2021

    • Author(s)
      Yokota Chisato、Nakata Jun、Takano Koji、Nakajima Hiroko、Hayashibara Hiromu、Minagawa Hikaru、Chiba Yasuyoshi、Hirayama Ryuichi、Kijima Noriyuki、Kinoshita Manabu、Hashii Yoshiko、Tsuboi Akihiro、Oka Yoshihiro、Oji Yusuke、Kumanogoh Atsushi、Sugiyama Haruo、Kagawa Naoki、Kishima Haruhiko
    • Journal Title

      Neuro-Oncology Advances

      Volume: 3 Issue: 1 Pages: 1-10

    • DOI

      10.1093/noajnl/vdab091

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K18390, KAKENHI-PROJECT-19K08345, KAKENHI-PROJECT-19K09457, KAKENHI-PROJECT-19K18426
  • [Presentation] マウスグリオーマモデルに対するWT1ペプチドワクチン・抗PD-1抗体併用療法の検討2019

    • Author(s)
      横田千里、高野浩司、中田潤、皆川光、中島博子、林原 弘武、磯川和希、中川智義、平山龍一、木嶋教行、木下学、香川尚己、貴島晴彦
    • Organizer
      一般社団法人日本脳神経外科学会第78回学術総会
    • Data Source
      KAKENHI-PROJECT-19K18390
  • [Presentation] マウスグリオーマモデルに対するWT1ペプチドワクチン・抗PD-1抗体併用療法の検討2019

    • Author(s)
      横田千里、高野浩司、中田潤、皆川光、中島博子、林原 弘武、磯川和希、中川智義、平山龍一、木嶋教行、木下学、香川尚己、貴島晴彦
    • Organizer
      第20回日本分子脳神経外科学会
    • Data Source
      KAKENHI-PROJECT-19K18390

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi